← FDA Drug Approvals (Drugs@FDA)

ACETAMINOPHEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INFORLIFE · Approved 2023-05-03

Drug application

FDA Application #

ANDA215403

Application type

Abbreviated New Drug Application (Generic)

Brand name

ACETAMINOPHEN

Generic name

ACETAMINOPHEN

Active ingredients

ACETAMINOPHEN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

INFORLIFE

Manufacturer

WG Critical Care, LLC

First approval

2023-05-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown